Literature DB >> 15769610

Functions of the adenovirus E4 proteins and their impact on viral vectors.

Matthew D Weitzman1.   

Abstract

Viral vectors based on recombinant adenoviruses (rAd) are used extensively as gene delivery systems for investigations of gene function and gene therapy applications. In both cases, the desire is for efficient expression of a transgene without substantial toxicity to the target cell. The first generation of rAd vectors were deleted of early region E1 and sometimes additionally early region E3. Evaluation of these vectors in preclinical animal models revealed transient gene expression, accompanied by cytotoxicity and immune responses. Expression of remaining viral genes, even in the absence of the E1 region, contributes to these effects and therefore it is important to have an appreciation of the functions of these viral genes. In particular, the early region E4 has been shown to affect transgene persistence, vector toxicity and immunogenicity. Proteins from the E4 genes can modulate transcription, the cell-cycle, cell signaling and DNA repair. In addition, some of these proteins also cause oncogenic transformation. Therefore interactions of these viral genes with key cell regulators should be taken into account when engineering rAd vectors. This review will summarize our knowledge of E4 functions and the implications of recent findings on the development of rAd vectors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15769610     DOI: 10.2741/1604

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  26 in total

1.  Identification of a previously unrecognized promoter that drives expression of the UXP transcription unit in the human adenovirus type 5 genome.

Authors:  Baoling Ying; Ann E Tollefson; William S M Wold
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

2.  Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

Authors:  Nia Tatsis; Julie C Fitzgerald; Arturo Reyes-Sandoval; Kimberly C Harris-McCoy; Scott E Hensley; Dongming Zhou; Shih-Wen Lin; Ang Bian; Zhi Quan Xiang; Amaya Iparraguirre; Cesar Lopez-Camacho; E John Wherry; Hildegund C J Ertl
Journal:  Blood       Date:  2007-05-17       Impact factor: 22.113

3.  Distinct requirements of adenovirus E1b55K protein for degradation of cellular substrates.

Authors:  Rachel A Schwartz; Seema S Lakdawala; Heather D Eshleman; Matthew R Russell; Christian T Carson; Matthew D Weitzman
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

4.  Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and Replication.

Authors:  Bratati Saha; Robin J Parks
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

Review 5.  Adenovirus: the first effective in vivo gene delivery vector.

Authors:  Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2014-01       Impact factor: 5.695

6.  Host cell DNA repair pathways in adeno-associated viral genome processing.

Authors:  Vivian W Choi; Douglas M McCarty; R Jude Samulski
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

7.  Comparison of the Life Cycles of Genetically Distant Species C and Species D Human Adenoviruses Ad6 and Ad26 in Human Cells.

Authors:  Mallory A Turner; Sumit Middha; Sean E Hofherr; Michael A Barry
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

8.  Differential requirements of the C terminus of Nbs1 in suppressing adenovirus DNA replication and promoting concatemer formation.

Authors:  Seema S Lakdawala; Rachel A Schwartz; Kevin Ferenchak; Christian T Carson; Brian P McSharry; Gavin W Wilkinson; Matthew D Weitzman
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

Review 9.  New insights on adenovirus as vaccine vectors.

Authors:  Marcio O Lasaro; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2009-06-09       Impact factor: 11.454

Review 10.  Innate immunity to adenovirus.

Authors:  Rodinde Hendrickx; Nicole Stichling; Jorien Koelen; Lukasz Kuryk; Agnieszka Lipiec; Urs F Greber
Journal:  Hum Gene Ther       Date:  2014-04-08       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.